Generalized arterial calcification of infancy 1

Clinical trials for Generalized arterial calcification of infancy 1 explained in plain language.

Never miss a new study

Get alerted when new Generalized arterial calcification of infancy 1 trials appear

Sign up with your email to follow new studies for Generalized arterial calcification of infancy 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for babies: drug targets rare genetic disorder that hardens arteries

Disease control Ongoing

This study tests a new medicine called INZ-701 in babies up to 1 year old who have a rare genetic condition (ENPP1 deficiency) that causes severe hardening of the arteries and bone problems. The goal is to see if the drug can raise a key substance in the blood, improve survival, …

Matched conditions: GENERALIZED ARTERIAL CALCIFICATION OF INFANCY 1

Phase 3 • Sponsor: Inozyme Pharma • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC

Generalized arterial calcification of infancy 1

Get alerted when new Generalized arterial calcification of infancy 1 trials appear

New hope for babies: drug targets rare genetic disorder that hardens arteries